10 High Growth Dividend Paying Stocks To Invest In

6. Bristol-Myers Squibb Company (NYSE:BMY)

5-Year Revenue Growth: 13.06%

Bristol-Myers Squibb Company (NYSE:BMY) is a New York-based multinational pharmaceutical company that specializes in discovering and delivering innovative medicines. The company is steering its growth plans around a pipeline of innovative therapies, with a strong focus on its neuroscience treatment, Cobenfy. If ongoing clinical trials deliver favorable results, this drug could reshape the company’s future financial performance.

Bristol-Myers Squibb Company (NYSE:BMY)’s balanced approach—combining a solid dividend policy with strategic expansion—has positioned it as a compelling option for income-focused investors. In 2024, the approval of Cobenfy and Breyanzi are expected to be multi-billion-dollar revenue drivers moving forward. In the fourth quarter of 2024, the company’s Growth Portfolio generated $6.4 billion in revenue, reflecting a 21% year-over-year increase fueled by robust demand. Total revenue for the quarter came in at $12.34 billion, representing a 7.5% annual increase. In the past five years, the company’s revenue growth came in at over 13%, which makes it one of the best high growth stocks that pay dividends.

Bristol-Myers Squibb Company (NYSE:BMY)’s dividend-paying streak currently spans 93 years. The company also maintains a 16-year track record of dividend growth. It offers a quarterly dividend of $0.62 per share and has a dividend yield of 4.66%, as of April 8.